Asthma Management in the time of COVID-19

ABSTRACT

@#Asthma is a chronic inflammatory airway disease which results in variable expiratory airflow limitation. While there is currently no evidence that asthma increases the risk of COVID-19 or its severity of illness, new data emerges daily. This article outlines the recommendations by Global Initiative for Asthma (GINA), British Thoracic Society (BTS) and National Asthma Council Australia (NACA) which are relevant to primary care management of asthma in light of the COVID-19 pandemic.